Literature DB >> 12088958

The efficacy of lafutidine in improving preoperative gastric fluid property: a comparison with ranitidine and rabeprazole.

Takanobu Uesugi1, Katsuya Mikawa, Kahoru Nishina, Osamu Morikawa, Yumiko Takao, Hidefumi Obara.   

Abstract

IMPLICATIONS: Acid aspiration syndrome remains a potentially critical perioperative complication. We compared lafutidine, ranitidine, and rabeprazole for reduction of preoperative gastric fluid acidity and volume in elective surgery and found that these variables were minimized with a single morning dose of lafutidine 20 mg compared with ranitidine or rabeprazole. Preoperative oral lafutidine may be an alternative to ranitidine as a prophylaxis against aspiration pneumonia.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12088958     DOI: 10.1097/00000539-200207000-00025

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  4 in total

1.  An open-label, randomized, cross-over bioequivalence study of lafutidine 10 mg under fasting condition.

Authors:  Bhupesh Dewan; Raghuram Chimata
Journal:  World J Gastrointest Pharmacol Ther       Date:  2010-10-06

2.  Reducing gastric secretions--a role for histamine 2 antagonists or proton pump inhibitors in malignant bowel obstruction?

Authors:  K Clark; L Lam; D Currow
Journal:  Support Care Cancer       Date:  2009-03-17       Impact factor: 3.603

3.  Effect of preoperative intravenous pantoprazole in elective-surgery patients: a pilot study.

Authors:  Joseph R Pisegna; Robyn G Karlstadt; Jeffrey A Norton; Ronald Fogel; David S Oh; G Jay Graepel; Mary Beth Dorr
Journal:  Dig Dis Sci       Date:  2008-08-27       Impact factor: 3.199

4.  Lafutidine 10 mg versus Rabeprazole 20 mg in the Treatment of Patients with Heartburn-Dominant Uninvestigated Dyspepsia: A Randomized, Multicentric Trial.

Authors:  Bhupesh Dewan; Nisha Philipose
Journal:  Gastroenterol Res Pract       Date:  2011-05-05       Impact factor: 2.260

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.